Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Endocrinology and Metabolism ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- American diabetes Association website.(Available at:)https://diabetes.org/about-us(Accessed 16 August 2022)Date: 1995
- The discovery of insulin.25th Anniversary Edition. The University of Chicago, 2007
- Reversing type 2 diabetes: a narrative review of the evidence.Nutrients. 2019; 11: 766
- How do we define cure of diabetes?.Diabetes Care. 2009; 32: 2133-2135
- Consensus report: definition and interpretation of remission in type 2 diabetes.J Clin Endocrinol Metab. 2022; 107: 1-9
- Diabetes and operation.: a note on the effect of gastro-jejunostomy upon a case of mild diabetes mellitus with a low renal threshold.Lancet. 1925; 206: 1162-1163
- Who would have thought it? an operation proves to be the most effective therapy for adult-onset diabetes mellitus.Ann Surg. 1995; 222: 339-350
- Can small bowel resection be defended as therapy for obesity?.Nordisk Medicin. 1952; 47: 744
- Can small bowel resection be defended as therapy for obesity?.Obes Surg. 1994; 1: 54-55
- The amelioration of diabetes mellitus following subtotal gastrectomy.Surg Gynecol Obstet. 1955; 100: 201-204
- Remissions of diabetes mellitus after weight reduction by jejunoileal bypass.Diabetes Care. 1978; 1: 158-165
- Improvement in obesity-associated medical conditions following vertical banded gastroplasty and gastrointestinal bypass.Obes Surg. 1994; 4: 227-231
- Biliopancreatic diversion.World J Surg. 1998; 22: 936-946
- Biliopancreatic diversion with a duodenal switch.Obes Surg. 1998; 8: 267-282
- Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.JAMA. 2008; 299: 316-323
- Effect of sleeve gastrectomy on patients with diabetes mellitus.Surg Obes Relat Dis Off J Am Soc Bariatric Surg. 2009; 5: 429-434
- Severe diabetes with remission: report of a case and review of the literature.N Engl J Med. 1957; 257: 257-261
- Remission in diabetes.Br Med J. 1959; 2: 731
- Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.Lancet Diabetes Endocrinol. 2013; 1: 28-34
- Association of an intensive lifestyle intervention with remission of type 2 diabetes.Jama. 2012; 308: 2489-2496
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.Lancet Diabetes Endocrinol. 2019; 7: 344-355
- American diabetes association; american college of cardiology foundation; american heart association. intensive glycemic control and the prevention of cardiovascular events:implications of the accord, advance, and va diabetes trials. a position statement of the american diabetes association and a scientific statement of the american college of cardiology foundation and the american heart association.Diabetes Care. 2009; 32: 187-192
- Action to control cardiovascular risk in diabetes study group. effects of intensive glucose lowering in type 2 diabetes.N Engl J Med. 2008; 358: 2545-2559
- Investigators of the VADT. the duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial.J Diabetes Complications. 2011; 25: 355-361
- The Look AHEAD research group. end-of-trial health outcomes in look ahead participants who elected to have bariatric surgery.Obesity (Silver Spring). 2019; 27: 581-590
- Effect of intensive lifestyle intervention on Body weight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallelgroup, randomised controlled trial.Lancet Diabetes Endocrinol. 2020; 8: 477-489
- Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.Lancet. 2008; 371: 1753-1760
- β-cell failure in diabetes and preservation by clinical treatment.Endocr Rev. 2007; 28: 187-218
- Induction of long-term glycaemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.Diabetes Care. 1997; 20: 1353-1356
- Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.Diabet Med. 2001; 18: 10-16
- Short-term intensive insulin therapy in newly diagnosed type 2 diabetes.Diabetes Care. 2004; 27: 1028-1032
- Induction of long-term glycaemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.Diabetes Care. 2004; 27: 2597-2602
- The effect of continuous subcutaneous insulin infusion (CSII) on glucose metabolism and induction of long-term glycemic control in newly diagnosed type 2 diabetic patients (Abstract).Diabetes. 2004; 53: A112
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Lancet. 2014; 383: 1068-1083
- Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis.Diabetes Res Clin Pract. 2018; 137: 137-148
- Trends in diabetes treatment and control in U.S. adults, 1999-2018.N Engl J Med. 2021; 384: 2219-2228
- Estimate of bariatric surgery numbers, 2011-2020.(Available at:) (Accessed Oct 31, 2022)
- Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes.Diabetes Care. 2016; 39: 902-911
- Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations.Diabetes care. 2016; 39: 861-877
- American society for metabolic and bariatric surgery 2020 estimate of metabolic and bariatric procedures performed in the United States.Surg Obes Relat Dis. 2022; 18: 1134-1140
- Risks and benefits of bariatric surgery: current evidence.Cleve Clin J Med. 2006; 73: 993
- How safe is metabolic/diabetes surgery?.Diabetes Obes Metab. 2015; 17: 198-201
- Changes in utilization of bariatric surgery in the United States from 1993 to 2016.Ann Surg. 2020; 271: 201-209
- Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.JAMA. 2014; 311: 2297-2304
- Diabetes remission status during seven-year follow-up of the longitudinal assessment of bariatric surgery study.J Clin Endocrinol Metab. 2021; 106: 774-788
- Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.Lancet. 2021; 397: 293-304
- STAMPEDE investigators. metabolic surgery vs. intensive medical therapy for diabetes: 5-year outcomes.N Engl J Med. 2017; 376: 641-651
- Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-year outcomes from a randomized trial.J Clin Endocrinol Metab. 2020; 105: 866-876
- lifestyle intervention and medical management with vs without roux-en-y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study.JAMA. 2018; 319: 266-278
- Effect of laparoscopic sleeve gastrectomy vs roux-en-y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the sleevepass randomized clinical trial.JAMA Surg. 2022; 157: 656-666
- Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial.JAMA. 2018; 319: 255-265
- Can diabetes be surgically cured?: long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus.Ann Surg. 2013; 258: 628
- Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities.JAMA. 2018; 319: 291-301
- Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.Diabetologia. 2019; 62: 611-620
- Comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass: the National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.JAMA Surg. 2020; 155: e200087
- Bariatric surgery versus conventional medical therapy for type 2 diabetes.N Engl J Med. 2012; 366: 1577-1585
- Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial.Lancet. 2015; 386: 964-973
- Bariatric surgery versus intensive medical therapy in obese patients with diabetes.N Engl J Med. 2012; 366: 1567-1576
- STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes.N Engl J Med. 2014; 370: 2002-2013
- Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.JAMA. 2013; 309: 2240-2249
- Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomized, controlled trial.Lancet Diabetes Endocrinol. 2015; 3: 413-422
- Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial.JAMA Surg. 2014; 149: 707-715
- Three-year outcomes of bariatric surgery vs. lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial.JAMA Surg. 2015; 150: 931-940
- Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D).Diabetes Care. 2022; 45: 1574-1583
- Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial.Lancet Diabetes Endocrinol. 2014; 2: 545-552
Shah SS, Todkar J, Phadake U, et al. Gastric bypass vs. medical/lifestyle care for type 2 diabetes in South Asians with BMI 25-40 kg/m2: the COSMID randomized trial [261-OR]. Presented at the American Diabetes Association’s 76th Scientific Session; June 10–14, 2016; New Orleans, LA.
- Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial.JAMA Surg. 2020; 155: e200420
- Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial.Diabetes Res Clin Pract. 2013; 101: 50-56
- Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.JAMA Surg. 2014; 149: 716-726
- Adjustable gastric band surgery or medical management in patients with type 2 diabetes: a randomized clinical trial.J Clin Endocrinol Metab. 2015; 100: 2546-2556
- Gastric bypass surgery vs. intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomized controlled trial.Diabetologia. 2016; 59: 945-953
- Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do not meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success.Ann Surg. 2014; 260: 617-622
- PCORnet Bariatric Study Collaborative. Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study.Ann Intern Med. 2018; 169: 741-750
- PCORnet Bariatric Study Collaborative. Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.JAMA Surg. 2020; 155: e200087
- Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial.JAMA Surg. 2015; 150: 352-361
- Long-term resolution of type 2 diabetes after biliopancreatic diversion and duodenal switch procedure: a retrospective analysis from a high-volume institution.Surg Obes Relat Dis. 2022; S1550-7289: 00181-00182
- Long-term results after sleeve gastrectomy: a systematic review.Surg Obes Relat Dis. 2017; 13: 693-699
- Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up.Surg Endosc. 2011; 25: 292-297
- Biliopancreatic diversion in the surgical treatment of morbid obesity: long-term results and metabolic consequences.Obes Surg. 2020; 30: 4234-4242
- Long-term metabolic outcomes 5 to 20 years after biliopancreatic diversion.Obes Surg. 2015; 25: 1584-1593
- systematic review and meta-analysis of randomised controlled trials comparing long-term outcomes of roux-en-y gastric bypass and sleeve gastrectomy.Obes Surg. 2020; 30: 664-672
- The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis.Obes Surg. 2017; 27: 2724-2732
- Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus.BJS. 2018; 105: 168-181
- Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms.Expert Rev Endocrinol Metab. 2018; 13: 251-262
- Effects of diet versus gastric bypass on metabolic function in diabetes.N Engl J Med. 2020; 383: 721-732
- A gut check explains improved glucose metabolism after surgery.Cell Metab. 2019; 30: 852-854
- Bariatric surgery and long-term cardiovascular events.JAMA. 2012; 307: 56-65
- For the look ahead research group. cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013; 369: 145-154
- Weight and metabolic outcomes 12 years after gastric bypass.N Engl J Med. 2017; 377: 1143-1155
- Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study.JAMA Surg. 2017; 153: 427-434
- Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.Am J Med. 2009; 122: 248-256
- Life expectancy after bariatric surgery in the Swedish obese subjects study.N Engl J Med. 2020; 383: 1535-1543
- Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis.JAMA. 2021; 326: 2031-2042
- Effect of bariatric surgery on long-term cardiovascular outcomes: a systematic review and meta-analysis of population-based cohort studies.Surg Obes Relat Dis. 2022; 18: 1074-1086
- The effects of metabolic surgery on microvascular complications in obese patients with type 2 diabetes: a meta-analysis.Surg Obes Relat Dis. 2021; 17: 434-443
- Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.Lancet. 2021; 397: 1830-1841
- Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis.JAMA Intern Med. 2018; 178: 28-36
- EMPA-REG outcome investigators. empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.N Engl J Med. 2015; 373: 2117-2128
- Statins for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2013; 2013: CD004816
- After 70 years, metabolic surgery has earned a cardiovascular outcome trial.Circulation. 2021; 143: 1481-1483
- NIH conference. gastrointestinal surgery for severe obesity.Ann Intern Med. 1991; 115: 956-961
- American diabetes association professional practice committee:. 8. obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes—2022.Diabetes Care. 2022; 45: S113-S124
- individualized metabolic surgery score: procedure selection based on diabetes severity.Ann Surg. 2017; 266: 650-657
- Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score.Surg Obes Relat Dis. 2013; 9: 379-384
- Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study.Lancet Diabetes Endocrinol. 2014; 2: 38-45
- DiaRem2: Incorporating duration of diabetes to improve prediction of diabetes remission after metabolic surgery.Surg Obes Relat Dis. 2019; 15: 717-724
- Performance and improvement of the DiaRem score in diabetes remission prediction: a study with diverse procedure types.Surg Obes Relat Dis. 2020; 16: 1531-1542
- Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT).Diabetic Med. 2021; 38: e14395
- Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes.BMJ Open Diabetes Res Care. 2016; 4: e000270
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
